1. Clinical trials of a mouse-human chimeric anti-CD20 monoclonal antibody (rituximab) for B cell non-Hodgkin's lymphoma in Japan

   • Kensei Tobinai

   Pages: S85 - S90

2. Histone deacetylase as a new target for cancer chemotherapy

   • Minoru Yoshida
   • Ryohei Furumai
   • Sueharu Horinouchi

   Pages: S20 - S26

3. Phosphatidyl inositol signaling by BCR/ABL: opportunities for drug development

   • James D. Griffin

   Pages: S11 - S16

4. Mechanisms of transcriptional repression by the t(8;21)-, t(12;21)-, and inv(16)-encoded fusion proteins

   • Scott W. Hiebert
   • Bart Lutterbach
   • Yue Hou

   Pages: S31 - S34

5. Evaluating the contribution of allogeneic and autologous transplantation to the management of acute myeloid leukemia in adults

   • Alan K. Burnett

   Pages: S53 - S58

6. STI571, a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia: validating the promise of molecularly targeted therapy

   • Michael J. Mauro
   • Michael E. O'Dwyer
   • Brian J. Druker

   Pages: S77 - S78

7. Analysis of prognostic factors in newly diagnosed patients with acute promyelocytic leukemia: the APL92 study of the Japan Adult Leukemia Study Group (JALSG)

   • Norio Asou
   • Koichi Adachi
   • Ryuzo Ohno

   Pages: S65 - S71

8. Radioimmunotherapy for patients with relapsed B-cell non-Hodgkin lymphoma

   • Thomas E. Witzig

   Pages: S91 - S95

9. Transport of intracellularly active ribozymes to the cytoplasm

   • Makoto Miyagishi
   • Tomoko Kuwabara
   • Kazunari Taira

   Pages: S96 - S101

10. Histone deacetylases and transcriptional therapy with their inhibitors

    • Pier Pandolfi

    Original Article Pages: S17 - S19

11. FLT3 tyrosine kinase as a target molecule for selective antileukemia therapy

    • Tomoki Naoe
    • Hitoshi Kiyoi
    • Hidehiko Saito

    Pages: S27 - S30

12. Oncogenic mechanisms of Evi-1 protein

    • Hisamaru Hirai
    • Koji Izutsu
    • Kinuko Mitani

    Pages: S35 - S40

13. Remission induction therapy: the more intensive the better?

    • Thomas Büchner
    • Wolfgang Hiddemann
    • Achim Heinecke

    Original Article Pages: S41 - S44

14. Multicenter prospective study of interferon-α versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia: a preliminary analysis

    • Kazunori Ohnishi
    • Teruo Ino
    • Ryuzo Ohno

    Pages: S59 - S64

15. Nonmyeloablative stem cell transplantation for the treatment of cancer and life-threatening nonmalignant disorders: past accomplishments and future goals

    • Shimon Slavin
    • Reuven Or
    • Arnon Nagler

    Pages: S79 - S84

16. Arsenic compounds as anticancer agents

    • Zhen-Yi Wang

    Pages: S72 - S76

17. New strategies for cancer therapy in the 21st century

    • Nagahiro Saijo
    • Tomohide Tamura
    • Kazuto Nishio

    Pages: S102 - S106

18. Preface

    • Hidehiko Saito
    • Makoto Ogawa
    • Ryuzo Ohno

    Pages: S1 - S3

19. Acute myeloid leukemia in adults: where do we go from here?

    • Charles A. Schiffer

    Original Article Pages: S45 - S52

20. Can we conquer cancer in the twenty-first century?

    • Emil J Freireich

    Pages: S4 - S10